Management of thrombophilia in renal transplant patients

American Journal of Transplantation

Volumn 2, Issue 9, 2002, Pages 872-876

  Morrissey, Paul E ^a   Ramirez, Pedro J ^a   Gohh, Reginald Y ^a   Yango, Angelito Y ^a   Kestin, Anita ^a   Madras, Peter N ^a   Monaco, Anthony P ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Antiphospholipid antibody; Renal transplantation; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; CYCLOSPORIN; CYCLOSPORIN A; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CADAVER KIDNEY; GRAFT REJECTION; HEMATOMA; HEPARINIZATION; HUMAN; HYPERCOAGULABILITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; LIVING DONOR; MAJOR CLINICAL STUDY; PROTEIN C DEFICIENCY; RENAL ARTERY THROMBOSIS; RISK FACTOR; SCREENING; THROMBOPHILIA; THROMBOSIS;

ANTICOAGULANTS; ASPIRIN; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PLATELET AGGREGATION INHIBITORS; THROMBOPHILIA; WARFARIN;

EID: 0036820255     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20910.x     Document Type: Article

References (17)

1. Humar A, Key N, Ramcharan T, Payne WD, Sutherland DER, Matas AJ. Kidney transplants after initial graft loss to vascular thrombosis. Clin Transplant 2001; 15: 6-10.
2. Penny MJ, Nankivell BJ, Disney APS, Byth K, Chapman JR. Renal graft thrombosis. a survey of 134 consecutive cases. Transplantation 1994; 58: 565-569.
3. Jordan ML, Cook GT, Cardella CJ. Ten years of experience with vascular complications in renal transplantation. J Urol 1982; 128: 689-692.
4. Smith RB, Ehrlich RM. The surgical complications of renal transplantation. Urol Clin N Am 1976; 3: 621-646.
5. Irish A. Renal allograft thrombosis can thrombophilia explain the inexplicable? Nephrol Dial Transplant 1999; 14: 2297-2303.
6. Rosendaal FR. Venous thrombosis a multicausal disease. Lancet 1999; 353: 1167-1173.
7. Vaidya S, Sellers R, Kimball P et al. Frequency potential risk and therapeutic intervention in ESRD patients with antiphospholipid antibody syndrome - a multicenter study. Transplantation 2000; 69: 1348-1352.
8. Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA. Antiphospho-lipid antibodies are a risk factor for early renal allograft failure. Transplantation 1999; 68: 241-246.
9. Bostom AG, Gohh RY, Morrissey P. Hyperhomocysteinemia in chronic renal transplant recipients. Graft 2000; 3: 195-204.
10. Friedman GS, Meier-Kriesche H, Kaplan B et al. Hypercoagulable states in renal transplant candidates: Impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation 2001; 72: 1073-1078.
11. Irish AB, Green FR, Gray DWR, Morris PJ, The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation 1997; 64: 604-607.
12. Abdou JC, Meier-Kriesche HU, Kaplan B et al. Allograft loss in renal transplant recipients with Fabry's Disease and activated protein C resistance. Transplantation 2000; 69: 2099-2102.
13. Lohse P, Appen KV, Samtleben W, Schlondorff D, Land W. Early loss of renal transplants in patients with thrombophilia. Transplantation 1998; 65: 936-939.
14. Nowak G, Nowak-Gottl U, Tonshoff B, Kreuz W. Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. Transplantation 1999; 68: 575-578.
15. Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplant candidates: Clinical Practice Guidelines. Am J Transplant 2001; 2: S5-S95.
16. Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001; 135: 367-373.
17. Diuguid DL. Oral anticoagulant therapy for venous thromboembolism. N Engl J Med 1997; 333: 433-434.